Royal Bank Of Canada reiterated their outperform rating on shares of Concordia Healthcare Corp (TSE:CXR) in a research report sent to investors on Wednesday morning, StockTargetPrices.com reports. They currently have a C$32.00 target price on the stock.
A number of other research firms have also weighed in on CXR. TD Securities reduced their price objective on Concordia Healthcare Corp from C$45.00 to C$37.00 and set a buy rating for the company in a research report on Tuesday, June 28th. Goldman Sachs Group Inc. set a C$34.00 price objective on Concordia Healthcare Corp in a research report on Friday, July 22nd. Finally, CIBC lowered Concordia Healthcare Corp from a sector perform rating to an underperform rating in a research report on Monday, August 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. Concordia Healthcare Corp has an average rating of Hold and an average price target of C$27.25.
Shares of Concordia Healthcare Corp (TSE:CXR) opened at 6.76 on Wednesday. The firm has a 50 day moving average price of $13.06 and a 200 day moving average price of $28.33. Concordia Healthcare Corp has a 52 week low of $6.33 and a 52 week high of $95.21. The company’s market capitalization is $344.87 million.
Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with MarketBeat.com's FREE daily email newsletter.